TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
NAGE

Niagen Bioscience, Inc.

Healthcare · Biotechnology · —

3.00$ -2.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NAGE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.07 -0.06 -0.08 -0.22 -0.38 -0.36 -0.17 -0.36 -0.22 0.09 0.15 0.16
0.01 0.01 0.01 0.02 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.02
0.08 0.06 0.03 0.10 0.12 0.13 0.11 0.09 0.08 0.06 0.05 0.07
-0.01 -0.06 -0.07 0.04 0.09 0.01 0.02 -0.07 -0.09 0.06 0.04 -0.10
0.01 0.02 0.05 0.03 0.03 0.01 0.00 0.01 0.00 0.00 0.00 0.00
0.04 -0.02 -0.05 0.10 -0.03 0.00 0.00 -0.01 0.00 0.00 0.00 0.00
– – – – -0.01 – – – – – 0.00 0.00
– – – – – – – 0.00 0.00 0.00 0.00 0.00
0.08 0.12 0.02 1.10 0.00 0.30 0.14 0.54 0.11 0.00 0.07 0.08
0.05 0.04 -0.10 0.98 -0.41 -0.07 -0.03 0.17 -0.11 0.09 0.22 0.24
-0.08 -0.08 -0.12 -0.25 -0.41 -0.37 -0.18 -0.37 -0.22 0.09 0.15 0.15

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?